Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Reticular pseudodrusen predicts late-stage AMD

Reticular pseudodrusen increases the likelihood of people with choroidal neovascularisation in one eye also developing late-stage, age-related macular degeneration in the other eye, researchers report.

28 Aug 2014

Lifestyle factors modify vision impairment risk

Smoking, drinking alcohol and physical activity are modifiable behaviours that influence the risk of vision impairment, show findings from the Beaver Dam Eye Study.

28 Aug 2014

Simple colour test could detect early onset of nAMD in the UK

A simple colour test that could detect the early onset of a condition which accounts for over half of visual impairment certifications in the UK is being researched by scientists at Aston University.

28 Aug 2014

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.

22 Aug 2014

Choroidal consequences differ between anti-VEGF therapies

Aflibercept’s possession of a fragment crystallisable region may make it more likely to induce unwanted effects in retinal and choroidal vessels than other anti-vascular endothelial growth factor therapies, say researchers.

20 Aug 2014

Risk factors for sporadic vision loss in AMD identified

Sporadic vision loss occurs in patients with age-related macular degeneration and impairs their future visual acuity, research shows.

20 Aug 2014

Focal choroidal excavation linked to chorioretinal diseases

Results of a Japanese study show that focal choroidal excavation is present in several ocular diseases, including typical age-related macular degeneration, central serous chorioretinopathy, polypoidal choroidal vasculopathy and idiopathic choroidal neovascularization.

20 Aug 2014

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

SHEFFIELD Teaching Hospitals NHS Foundation Trust has become the first NHS hospital in the UK to start offering its patients a new non-invasive treatment for wet age-related macular degeneration (wet AMD).

20 Aug 2014

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

iCo Therapeutics Inc., today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.

19 Aug 2014

FGF proteins play broad roles in wound healing

Mice missing two important proteins of the vascular system develop normally and appear healthy in adulthood, as long as they don't become injured. If they do, their wounds don't heal properly, a new study shows.

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Majority of adults need to double consumption of fruits and vegetables for crucial nutrition, health benefits

New research published in the September issue of the British Journal of Nutrition and featured in the just released Global Phytonutrient Report highlights a significant shortfall in fruit and vegetable consumption in people's diets around the world.

12 Aug 2014

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.

11 Aug 2014

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

6 Aug 2014

Researchers create most detailed molecular map for region associated with blinding diseases

Understanding eye diseases is tricky enough. Knowing what causes them at the molecular level is even more confounding.

3 Aug 2014

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

31 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

Montefiore-Einstein investigators to present new findings from eight abstracts at IFHNOS 2014

Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.

26 Jul 2014

Oraya Therapy now being offered at NHS hospital in the UK and at four prestigious university hospitals in Germany

Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.

22 Jul 2014

Parents severely underestimate time children spend on digital devices

According to the American Optometric Association (AOA), parents severely underestimate the time their children spend on digital devices. An AOA survey reports that 83 percent of children between the ages of 10 and 17 estimate they use an electronic device for three or more hours each day.

22 Jul 2014

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Reticular pseudodrusen predicts late-stage AMD

Lifestyle factors modify vision impairment risk

Simple colour test could detect early onset of nAMD in the UK

Penn Medicine launches CAROT to build novel therapies for retinal and ocular disorders

Choroidal consequences differ between anti-VEGF therapies

Risk factors for sporadic vision loss in AMD identified

Focal choroidal excavation linked to chorioretinal diseases

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

FGF proteins play broad roles in wound healing

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Majority of adults need to double consumption of fruits and vegetables for crucial nutrition, health benefits

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Researchers create most detailed molecular map for region associated with blinding diseases

Regeneron announces FDA approval of EYLEA Injection for DME treatment

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Montefiore-Einstein investigators to present new findings from eight abstracts at IFHNOS 2014

Oraya Therapy now being offered at NHS hospital in the UK and at four prestigious university hospitals in Germany

Parents severely underestimate time children spend on digital devices

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in